Cure My Disease

Don't miss your cure!

 Log in / Sign up

2,100 sarcoma survivors join landmark study to uncover hidden Long-Term effects

NCT ID NCT06482957

Recruiting now Knowledge-focused Sponsor: Vanderbilt-Ingram Cancer Center Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study follows 2,100 people of all ages who have had sarcoma, a rare cancer, to learn how the disease and its treatments affect them over time. Participants will fill out surveys, give blood, saliva, urine, stool, and tissue samples, and wear a FitBit to track activity. The goal is to better understand the long-term physical and emotional challenges survivors face, which could help improve future care and support.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SARCOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

sarcoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SARCOMA

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Vanderbilt University/Ingram Cancer Center

    RECRUITING

    Nashville, Tennessee, 37203, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••